(SNOA) Sonoma Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Sonoma Pharmaceuticals | (SNOA) share price targets
Complete technical analysis of Sonoma Pharmaceuticals (SNOA) by charts plus indicators, forecast predictions and share price targets for Sonoma Pharmaceuticals (SNOA)
Sonoma Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-17 View latest technical analysis
10 day averaged volume of Sonoma Pharmaceuticals is 99450
| Date | Daily Closing Price | Open | High | Low | Volume |
| 17 Thu Oct 2024 | 2.93 | 2.94 | 2.99 | 2.84 | 0.28 times |
| 16 Wed Oct 2024 | 2.94 | 2.95 | 3.12 | 2.84 | 0.365 times |
| 15 Tue Oct 2024 | 2.94 | 3.18 | 3.18 | 2.93 | 0.45 times |
| 14 Mon Oct 2024 | 3.08 | 3.25 | 3.32 | 2.92 | 1.464 times |
| 11 Fri Oct 2024 | 3.11 | 3.03 | 3.40 | 3.01 | 2.227 times |
| 10 Thu Oct 2024 | 3.00 | 2.86 | 3.10 | 2.83 | 2.489 times |
| 09 Wed Oct 2024 | 2.86 | 2.68 | 2.93 | 2.60 | 0.495 times |
| 08 Tue Oct 2024 | 2.67 | 2.65 | 2.77 | 2.52 | 0.665 times |
| 07 Mon Oct 2024 | 2.59 | 2.79 | 2.79 | 2.56 | 0.719 times |
| 04 Fri Oct 2024 | 2.78 | 2.84 | 2.89 | 2.72 | 0.538 times |
My analysis of stock is bearish for shortterm, and stock might move down till 2.8 or till 2.6. Use a stoploss of 3.02 and if the stock hits stoploss, then it can shoot up till 3.23
Share price targets for Sonoma Pharmaceuticals (SNOA)
| Target Type | Value |
| Downside Target | 0.15 |
| Downside Target | 0.16 |
| Downside Target | 0.21 |
| Downside Target | 0.30 |
| Downside Target | 0.47 |
| Downside Target | 2.52 |
| Downside Target | 2.70 |
| Downside Target | 2.84 |
| Upside Target | 3.05 |
| Upside Target | 3.32 |
| Upside Target | 3.40 |
| Upside Target | 3.47 |
| Upside Target | 3.89 |
| Upside Target | 5.93 |
Intraday share price targets for Sonoma Pharmaceuticals (SNOA)
| Target Type | Value |
| Downside Intraday Target | 2.74 |
| Downside Intraday Target | 2.55 |
| Upside Intraday Target | 3.22 |
| Upside Intraday Target | 3.51 |
| Upside Intraday Target | 3.03 |
Weekly technical analysis of Sonoma Pharmaceuticals (SNOA)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 17 Thu Oct 2024 | 2.93 | 3.25 | 3.32 | 2.84 | 0.388 times |
| 11 Fri Oct 2024 | 3.11 | 2.79 | 3.40 | 2.52 | 2.247 times |
| 04 Fri Oct 2024 | 2.78 | 3.16 | 3.33 | 2.72 | 0.525 times |
| 27 Fri Sep 2024 | 3.21 | 3.43 | 3.47 | 3.05 | 0.09 times |
| 20 Fri Sep 2024 | 3.46 | 3.64 | 5.93 | 3.34 | 35.587 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Sonoma Pharmaceuticals (SNOA)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 17 Thu Oct 2024 | 2.93 | 3.15 | 3.40 | 2.52 | 0.15 times |
| 30 Mon Sep 2024 | 3.07 | 3.25 | 5.93 | 2.70 | 0.196 times |
| 30 Fri Aug 2024 | 3.30 | 0.37 | 3.89 | 0.15 | 0.389 times |
| 31 Wed Jul 2024 | 0.37 | 0.21 | 0.47 | 0.21 | 0.47 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Sonoma Pharmaceuticals (SNOA)
Price action analysis of Sonoma Pharmaceuticals ( (SNOA) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Sonoma Pharmaceuticals ( (SNOA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Sonoma Pharmaceuticals ( (SNOA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Sonoma Pharmaceuticals ( (SNOA) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Sonoma Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Sonoma Pharmaceuticals in short term but the sell signal is initial and weak.
Sonoma Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Sonoma Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Sonoma Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.96 and Sonoma Pharmaceuticals (SNOA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Sonoma Pharmaceuticals (SNOA) stock. Volume based technical analysis of Sonoma Pharmaceuticals (SNOA) stock is negative.
Sonoma Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Sonoma Pharmaceuticals ( (SNOA) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Sonoma Pharmaceuticals ( (SNOA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Sonoma Pharmaceuticals ( (SNOA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Sonoma Pharmaceuticals ( (SNOA) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Sonoma Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Sonoma Pharmaceuticals in short term but the sell signal is initial and weak.
Sonoma Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Sonoma Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Sonoma Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.96 and Sonoma Pharmaceuticals (SNOA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Sonoma Pharmaceuticals (SNOA) stock. Volume based technical analysis of Sonoma Pharmaceuticals (SNOA) stock is negative.
Sonoma Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.